HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric A Strom Selected Research

Carcinoma (Carcinomatosis)

2/2004Potential applicability of balloon catheter-based accelerated partial breast irradiation after conservative surgery for breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric A Strom Research Topics

Disease

74Breast Neoplasms (Breast Cancer)
08/2022 - 01/2002
35Neoplasms (Cancer)
10/2021 - 01/2002
9Neoplasm Metastasis (Metastasis)
01/2019 - 08/2002
8Noninfiltrating Intraductal Carcinoma (DCIS)
11/2021 - 09/2002
4Inflammatory Breast Neoplasms
01/2014 - 01/2002
3Edema (Dropsy)
01/2019 - 03/2002
3Seroma
01/2019 - 05/2004
2Fibrosis (Cirrhosis)
01/2019 - 07/2002
2Wounds and Injuries (Trauma)
01/2013 - 05/2004
2Necrosis
01/2013 - 05/2004
2Margins of Excision
10/2008 - 02/2003
2Pathologic Complete Response
07/2007 - 09/2005
2Pneumonia (Pneumonitis)
11/2004 - 07/2002
1Obesity
10/2021
1Pain (Aches)
01/2019
1Lobular Carcinoma
07/2018
1Cellulitis
10/2017
1Fatigue
10/2015
1Overweight
10/2015
1Disease Progression
10/2013
1Erythema
01/2013
1Dermatitis
07/2012
1Unilateral Breast Neoplasms
02/2012
1Hypothyroidism
03/2008
1Extranodal Extension
06/2005
1Radiation Pneumonitis
11/2004
1Thrombosis (Thrombus)
05/2004
1Hematoma
05/2004
1Ataxia Telangiectasia (Louis Bar Syndrome)
04/2004
1Carcinoma (Carcinomatosis)
02/2004
1Second Primary Neoplasms (Neoplasms, Second)
10/2003
1Fat Necrosis
07/2002
1Rib Fractures (Rib Fracture)
07/2002
1Lymphatic Metastasis
03/2002
1Melanoma (Melanoma, Malignant)
03/2002

Drug/Important Bio-Agent (IBA)

11Doxorubicin (Adriamycin)FDA LinkGeneric
08/2011 - 10/2003
9Estrogen ReceptorsIBA
01/2015 - 10/2003
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
07/2011 - 10/2003
5Hormones (Hormone)IBA
03/2022 - 10/2004
5Fluorouracil (Carac)FDA LinkGeneric
07/2011 - 11/2004
4TamoxifenFDA LinkGeneric
11/2021 - 01/2002
3Paclitaxel (Taxol)FDA LinkGeneric
07/2011 - 11/2004
3Progesterone Receptors (Progesterone Receptor)IBA
04/2011 - 02/2003
2Protons (Proton)IBA
01/2021 - 05/2016
2Trastuzumab (Herceptin)FDA Link
10/2012 - 08/2010
2taxaneIBA
07/2011 - 11/2004
2Estrogens (Estrogen)FDA Link
08/2010 - 02/2003
2human ERBB2 proteinIBA
08/2010 - 04/2010
2Biological ProductsIBA
12/2006 - 04/2005
2AnthracyclinesIBA
11/2006 - 08/2002
1Capecitabine (Xeloda)FDA Link
11/2017
1ixabepilone (BMS 247550)FDA Link
01/2013
1Petrolatum (Vaseline)FDA Link
07/2012
1antineoplaston A10 (A 10)IBA
07/2012
1EmulsionsIBA
07/2012
1Hyaluronic Acid (Hyaluronan)IBA
07/2012
1Biomarkers (Surrogate Marker)IBA
04/2011
1Methotrexate (Mexate)FDA LinkGeneric
03/2010
1Docetaxel (Taxotere)FDA Link
03/2010
14-azidobenzylcarazolol (pABC)IBA
03/2009
1Taxoids (Taxanes)IBA
10/2008
1SteroidsIBA
11/2004
1Complementary DNA (cDNA)IBA
04/2004

Therapy/Procedure

52Radiotherapy
08/2022 - 01/2002
25Mastectomy (Mammectomy)
11/2017 - 01/2002
24Segmental Mastectomy (Lumpectomy)
11/2021 - 07/2002
21Drug Therapy (Chemotherapy)
10/2021 - 01/2002
15Neoadjuvant Therapy
01/2014 - 01/2002
14Therapeutics
10/2021 - 03/2002
6Adjuvant Chemotherapy
06/2014 - 07/2002
3Brachytherapy
01/2019 - 11/2003
3Salvage Therapy
10/2013 - 11/2002
3Adjuvant Radiotherapy
07/2012 - 10/2006
3Aftercare (After-Treatment)
10/2004 - 09/2002
2Lymph Node Excision (Lymph Node Dissection)
08/2022 - 09/2010
2Surgical Instruments (Clip)
01/2021 - 12/2007
2Mammaplasty (Breast Reconstruction)
09/2006 - 05/2004
1Contraindications
10/2018
1Tissue Expansion Devices (Tissue Expander)
10/2017
1Skin Transplantation (Skin Grafting)
01/2013
1Modified Radical Mastectomy (Mastectomy, Modified)
03/2009
1Combined Modality Therapy
12/2008
1Perforator Flap
05/2004
1Catheters
02/2004
1Chemoprevention
11/2002
1Conservative Treatment
11/2002